These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 10513671)
1. Reply. Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. Gonzalez A; Everall I AIDS; 1999 Oct; 13(14):1996. PubMed ID: 10513671 [No Abstract] [Full Text] [Related]
2. Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. Colebunders R; Verdonck K AIDS; 1999 May; 13(7):869. PubMed ID: 10357394 [No Abstract] [Full Text] [Related]
9. [Results of the AIDS-In-Europe Study. Non-nucleoside reverse transcriptase inhibitor does not equal non-nucleoside reverse transcriptase inhibitor]. MMW Fortschr Med; 2001 Apr; 143 Suppl 1():39. PubMed ID: 11373776 [No Abstract] [Full Text] [Related]
10. Factors affecting adherence and convenience in antiretroviral therapy. Lafeuillade A Int J STD AIDS; 2001 Nov; 12 Suppl 4():18-24. PubMed ID: 11589824 [No Abstract] [Full Text] [Related]
11. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. Caso JA; Prieto Jde M; Casas E; Sanz J AIDS; 2001 Jul; 15(11):1447-8. PubMed ID: 11504970 [No Abstract] [Full Text] [Related]
13. Four-drug regimens may be better. AIDS Patient Care STDS; 2000 Dec; 14(12):671. PubMed ID: 11119435 [No Abstract] [Full Text] [Related]
14. Myelomeningocele in a child with intrauterine exposure to efavirenz. Fundarò C; Genovese O; Rendeli C; Tamburrini E; Salvaggio E AIDS; 2002 Jan; 16(2):299-300. PubMed ID: 11807320 [No Abstract] [Full Text] [Related]
15. Switching from protease inhibitors to the non-nuke efavirenz. TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089 [No Abstract] [Full Text] [Related]
16. Non-nucleoside reverse transcriptase inhibitors--an overview. Bell C; Matthews GV; Nelson MR Int J STD AIDS; 2003 Feb; 14(2):71-7. PubMed ID: 12662384 [No Abstract] [Full Text] [Related]
17. Female sex but not ethnicity is a strong predictor of non-nucleoside reverse transcriptase inhibitor-induced rash. Mazhude C; Jones S; Murad S; Taylor C; Easterbrook P AIDS; 2002 Jul; 16(11):1566-8. PubMed ID: 12131201 [No Abstract] [Full Text] [Related]